Contract valid for 3 years begining 01 Janaury 2015
Cipla announced that it has been awarded USD 188.95 million of Global Fund ARV Tender. Cipla has been selected as a 'Panel Supplier' for a Supplier Partnership Agreement. The contract is effective from the 1st of January 2015 and will run for a period of three years. The supplies will begin from Q4 FY 2015.Cipla has a long-term association with Global Fund since 2002. Last year, Cipla has been one of the suppliers who has been awarded with a long-term contract for supplying anti-malarial drugs.
The anti-retrovirals drugs will be manufactured in Cipla's state-of-the-art manufacturing facilities in India, which has been approved by various international regulatory agencies.
Powered by Capital Market - Live News
